{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:08:40Z","timestamp":1761059320144},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.2478\/v10039-012-0021-y","type":"journal-article","created":{"date-parts":[[2012,4,20]],"date-time":"2012-04-20T01:05:27Z","timestamp":1334883927000},"page":"169-173","source":"Crossref","is-referenced-by-count":8,"title":["Unexpected cure from cutaneous leukocytoclastic vasculitis in a patient treated with N-butyldeoxynojirimycin (miglustat) for Gaucher disease"],"prefix":"10.1016","volume":"57","author":[{"given":"M","family":"Machaczka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Klimkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"H\u00e4gglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.2478\/v10039-012-0021-y_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum Mutat."},{"issue":"9645","key":"10.2478\/v10039-012-0021-y_bib2","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet."},{"issue":"Suppl","key":"10.2478\/v10039-012-0021-y_bib3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejim.2006.07.005","article-title":"Epidemiology and natural history of Gaucher's disease","volume":"17","author":"Mehta","year":"2006","journal-title":"Eur J Intern Med."},{"issue":"1","key":"10.2478\/v10039-012-0021-y_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/03009734.2011.641609","article-title":"Substrate reduction therapy with miglustat for type 1 Gaucher disease: A retrospective analysis from a single institution","volume":"117","author":"Machaczka","year":"2012","journal-title":"Ups J Med Sci."},{"issue":"6","key":"10.2478\/v10039-012-0021-y_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/030097401317148499","article-title":"Leucocytoclastic vasculitis: an update for the clinician","volume":"30","author":"Koutkia","year":"2001","journal-title":"Scand J Rheumatol."},{"issue":"4","key":"10.2478\/v10039-012-0021-y_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MAJ.0b013e31815e8c0b","article-title":"Cutaneous leukocytoclastic vasculitis and myelodysplastic syndrome with little or no evidence of associated autoimmune disorders \u2013 a case report and a brief review of the literature","volume":"336","author":"Das","year":"2008","journal-title":"Am J Med Sci."},{"issue":"10","key":"10.2478\/v10039-012-0021-y_bib7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ajh.21492","article-title":"Treatment of multiple myeloma in patients with Gaucher disease","volume":"84","author":"Machaczka","year":"2009","journal-title":"Am J Hematol."},{"issue":"3","key":"10.2478\/v10039-012-0021-y_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.1984.tb04731.x","article-title":"Cutaneous manifestations of Gaucher disease","volume":"111","author":"Goldblatt","year":"1984","journal-title":"Br J Dermatol."},{"issue":"4","key":"10.2478\/v10039-012-0021-y_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"Gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Baillieres Clin Haematol."},{"issue":"4","key":"10.2478\/v10039-012-0021-y_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1399-0004.2006.00589.x","article-title":"Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease","volume":"69","author":"Holleran","year":"2006","journal-title":"Clin Genet."},{"issue":"11","key":"10.2478\/v10039-012-0021-y_bib11","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J Biol Chem."},{"issue":"15","key":"10.2478\/v10039-012-0021-y_bib12","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/QAD.0b013e32830efd96","article-title":"N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery","volume":"22","author":"Pollock","year":"2008","journal-title":"AIDS."},{"issue":"6","key":"10.2478\/v10039-012-0021-y_bib13","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1073\/pnas.91.6.2235","article-title":"Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin","volume":"91","author":"Block","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"10.2478\/v10039-012-0021-y_bib14","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1128\/JVI.69.9.5791-5797.1995","article-title":"The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding","volume":"69","author":"Fischer","year":"1995","journal-title":"J Virol."},{"issue":"1","key":"10.2478\/v10039-012-0021-y_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/viro.2002.1370","article-title":"Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions","volume":"295","author":"Jordan","year":"2002","journal-title":"Virology."},{"issue":"8","key":"10.2478\/v10039-012-0021-y_bib16","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1128\/JVI.76.8.3596-3604.2002","article-title":"Antiviral effects of an iminosugar derivative on flavivirus infections","volume":"76","author":"Wu","year":"2002","journal-title":"J Virol."},{"issue":"1","key":"10.2478\/v10039-012-0021-y_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2006.03.016","article-title":"Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3","volume":"72","author":"Tanaka","year":"2006","journal-title":"Antiviral Res."},{"issue":"Pt 4","key":"10.2478\/v10039-012-0021-y_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1099\/vir.0.82465-0","article-title":"Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors","volume":"88","author":"Chapel","year":"2007","journal-title":"J Gen Virol."},{"issue":"5","key":"10.2478\/v10039-012-0021-y_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00042560-199510050-00008","article-title":"The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100). The AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious Diseases","volume":"10","author":"Tierney","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol."},{"issue":"1433","key":"10.2478\/v10039-012-0021-y_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1098\/rstb.2003.1272","article-title":"Gaucher disease and the clinical experience with substrate reduction therapy","volume":"358","author":"Zimran","year":"2003","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"issue":"6","key":"10.2478\/v10039-012-0021-y_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jcf.2008.06.002","article-title":"Anti-inflammatory effect of miglustat in bronchial epithelial cells","volume":"7","author":"Dechecchi","year":"2008","journal-title":"J Cyst Fibros."},{"issue":"4","key":"10.2478\/v10039-012-0021-y_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1165\/rcmb.2010-0457OC","article-title":"Modulators of sphingolipid metabolism reduce lung inflammation","volume":"45","author":"Dechecchi","year":"2011","journal-title":"Am J Respir Cell Mol Biol."}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112614601279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112614601279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/versita.metapress.com\/index\/6943207L520086V8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T12:01:38Z","timestamp":1642075298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112614601279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1896112614601279"],"URL":"https:\/\/doi.org\/10.2478\/v10039-012-0021-y","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}